From SARS-CoV-2 to analgesia: harnessing the vascular endothelial growth factor A/neuropilin 1 axis for pain therapy

Affiliations

Editorial

Emilio R Mustafá et al. Pain. 2023.

. 2023 Jul 1;164(7):1403-1405.

doi: 10.1097/j.pain.0000000000002851. Epub 2022 Dec 15.

¹ Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

No abstract available

Comment on

VEGF in Signaling and Disease: Beyond Discovery and Development.
Apte RS, Chen DS, Ferrara N. Apte RS, et al. Cell. 2019 Mar 7;176(6):1248-1264. doi: 10.1016/j.cell.2019.01.021. Cell. 2019. PMID: 30849371 Free PMC article. Review.
Targeting the vascular endothelial growth factor A/neuropilin 1 axis for relief of neuropathic pain.
Stratton HJ, Boinon L, Gomez K, Martin L, Duran P, Ran D, Zhou Y, Luo S, Perez-Miller S, Patek M, Ibrahim MM, Patwardhan A, Moutal A, Khanna R. Stratton HJ, et al. Pain. 2023 Jul 1;164(7):1473-1488. doi: 10.1097/j.pain.0000000000002850. Epub 2022 Dec 19. Pain. 2023. PMID: 36729125 Free PMC article.

1. Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell 2019;176:1248–1264.
1. Beazley-Long N, Hua J, Jehle T, Hulse RP, Dersch R, Lehrling C, Bevan H, Qiu Y, Lagrèze WA, Wynick D, Churchill AJ, Kehoe P, Harper SJ, Bates DO, Donaldson LF. VEGF-A165b is an endogenous neuroprotective splice isoform of vascular endothelial growth factor A in vivo and in vitro. Am J Pathol 2013;183:918–929.
1. Beazley-Long N, Moss CE, Ashby WR, Bestall SM, Almahasneh F, Durrant AM, Benest AV, Blackley Z, Ballmer-Hofer K, Hirashima M, Hulse RP, Bates DO, Donaldson LF. VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis. Brain Behav Immun 2018;74:49–67.
1. De Bandt M, Ben Mahdi MH, Ollivier V, Grossin M, Dupuis M, Gaudry M, Bohlen P, Lipson KE, Rice A, Wu Y, Gougerot-Pocidalo MA, Pasquier C. Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol 2003;171:4853–4859.
1. De Rossi P, Harde E, Dupuis JP, Martin L, Chounlamountri N, Bardin M, Watrin C, Benetollo C, Pernet-Gallay K, Luhmann HJ, Honnorat J, Malleret G, Groc L, Acker-Palmer A, Salin PA, Meissirel C. A critical role for VEGF and VEGFR2 in NMDA receptor synaptic function and fear-related behavior. Mol Psychiatry 2016;21:1768–1780.